Prime Therapeutics is committed to simplifying the patient journey for those with complex conditions through its industry-leading HighTouchRx product

Findings also show improved persistence with high-potency, obesity-approved GLP-1 products

Event features discussions about health care industry trends, best practices and innovations

Formulary design recommendations help create competition to drive savings, provide optionality to meet unique client needs.

Leading GLP-1 persistence, adherence and clinical outcomes research helps inform health plans and members

Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.

Urick, senior principal health outcomes researcher, shares more about his Spotlight Session at the Academy of Managed Care Pharmacy (AMCP)’s Annual Meeting

Prime Therapeutics clinical experts shared insights on the specialty drug pipeline at recent industry event

A look at the specialty landscape and how Prime delivers value to employers

Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024

Prime Therapeutics researchers share how the model helps to optimize drug therapy and lower costs

Table view Editor-in-chief's message Year 2024 2025 2026 2027 2028 Projected Yearly U.S. Sales $0 $82 $177 $258 $311 The pipeline drug list is an aerial outline of drugs with anticipated FDA...

Prime Therapeutics offers innovative medication management solutions, supports patients with chronic conditions

Abby Kim, PharmD, BCOP, senior director of oncology, clinical strategy and specialty solutions at Prime Therapeutics, examines the trends payers should watch as cancer care becomes more complex

Abby Kim, PharmD, BCOP, is a senior director, clinical strategy and oncology specialty solutions, shares key takeaways from the American Journal of Managed Care (AJMC) forum, “Bridging evidence and...

Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...

Prime simplifies the cancer care pathway through innovative solutions that help manage complex conditions

In the latest episode of the “Pharmacy Friends” podcast, hear more about what faster drug decisions could mean for evidence review, affordability assessment and implementation planning

From new treatment options for dry eye disease to type 2 diabetes, here are a few of the top U.S. Food and Drug Administration drug decisions expected this year

Prime works to simplify medication management and support patients with migraine, making migraine treatment less of a pain point